Dengvaxia : Sanofi Pasteur rolls out world’s first dengue vaccine in Guatemala

Dengvaxia : Sanofi Pasteur rolls out world’s first dengue vaccine in Guatemala

Sanofi Pasteur, the French pharmaceutical giant, has announced the rollout of Dengvaxia, the world’s first dengue vaccine, in Guatemala in the upcoming days. This significant development was revealed at a news conference in Guatemala City, marking a crucial step in the fight against dengue fever, a mosquito-borne viral infection that poses severe global health challenges. […]

Amgen’s Parsabiv receives EC approval in secondary hyperparathyroidism

Amgen’s Parsabiv receives EC approval in secondary hyperparathyroidism

Amgen Inc., a leading American biopharmaceutical company, has achieved a significant milestone with the approval of its drug Parsabiv (etelcalcetide) by the European Commission (EC) for the treatment of secondary hyperparathyroidism (sHPT) in adult patients undergoing hemodialysis due to chronic renal disease. Breakthrough in sHPT Management sHPT is a complex and chronic condition that affects […]

Sun Pharma collaborates with ICGEB to develop affordable dengue vaccine

Sun Pharma collaborates with ICGEB to develop affordable dengue vaccine

Sun Pharma, an Indian multinational pharmaceutical company, has announced a collaboration with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a new dengue vaccine aimed at being safer, more effective, and more affordable than existing vaccines. This initiative marks the second collaboration between Sun Pharma and ICGEB, building on their earlier partnership […]